Clinical trials
Phase 1/2 Leukemia, Biphenotypic, Acute trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 11 |
| Active, not recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 7 |
| M.D. Anderson Cancer Center | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| University of Washington | 2 |
| AVM Biotechnology Inc | 1 |
| Cancer Treatment Centers of America | 1 |
| Children's Oncology Group | 1 |
| Kura Oncology, Inc. | 1 |
| National Cancer Institute (NCI) | 1 |
| Northwestern University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Biphenotypic, Acute | 26 |
| Leukemia, Myeloid, Acute | 22 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 17 |
| Leukemia | 13 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 8 |
| Leukemia, Myelomonocytic, Chronic | 8 |
| Lymphoma | 8 |
| Lymphoma, Follicular | 8 |
| Lymphoma, Large B-Cell, Diffuse | 8 |
| Lymphoma, Mantle-Cell | 8 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.